Show simple item record

dc.contributor.authorBoult, JKR
dc.contributor.authorBorri, M
dc.contributor.authorJury, A
dc.contributor.authorPopov, S
dc.contributor.authorBox, G
dc.contributor.authorPerryman, L
dc.contributor.authorEccles, SA
dc.contributor.authorJones, C
dc.contributor.authorRobinson, SP
dc.date.accessioned2016-08-17T12:29:05Z
dc.date.issued2016-11-01
dc.identifier.citationNMR in biomedicine, 2016, 29 (11), pp. 1608 - 1617
dc.identifier.issn0952-3480
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/57
dc.identifier.eissn1099-1492
dc.identifier.doi10.1002/nbm.3594
dc.description.abstractHigh grade and metastatic brain tumours exhibit considerable spatial variations in proliferation, angiogenesis, invasion, necrosis and oedema. Vascular heterogeneity arising from vascular co-option in regions of invasive growth (in which the blood-brain barrier remains intact) and neoangiogenesis is a major challenge faced in the assessment of brain tumours by conventional MRI. A multiparametric MRI approach, incorporating native measurements and both Gd-DTPA (Magnevist) and ultrasmall superparamagnetic iron oxide (P904)-enhanced imaging, was used in combination with histogram and unsupervised cluster analysis using a k-means algorithm to examine the spatial distribution of vascular parameters, water diffusion characteristics and invasion in intracranially propagated rat RG2 gliomas and human MDA-MB-231 LM2-4 breast adenocarcinomas in mice. Both tumour models presented with higher ΔR1 (the change in transverse relaxation rate R1 induced by Gd-DTPA), fractional blood volume (fBV) and apparent diffusion coefficient than uninvolved regions of the brain. MDA-MB-231 LM2-4 tumours were less densely cellular than RG2 tumours and exhibited substantial local invasion, associated with oedema, whereas invasion in RG2 tumours was minimal. These additional features were reflected in the more heterogeneous appearance of MDA-MB-231 LM2-4 tumours on T2 -weighted images and maps of functional MRI parameters. Unsupervised cluster analysis separated subregions with distinct functional properties; areas with a low fBV and relatively impermeable blood vessels (low ΔR1 ) were predominantly located at the tumour margins, regions of MDA-MB-231 LM2-4 tumours with relatively high levels of water diffusion and low vascular permeability and/or fBV corresponded to histologically identified regions of invasion and oedema, and areas of mismatch between vascular permeability and blood volume were identified. We demonstrate that dual contrast MRI and evaluation of tissue diffusion properties, coupled with cluster analysis, allows for the assessment of heterogeneity within invasive brain tumours and the designation of functionally diverse subregions that may provide more informative predictive biomarkers.
dc.formatPrint-Electronic
dc.format.extent1608 - 1617
dc.languageeng
dc.language.isoeng
dc.publisherWILEY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectCell Line, Tumor
dc.subjectAnimals
dc.subjectMice
dc.subjectMice, Nude
dc.subjectRats
dc.subjectBrain Neoplasms
dc.subjectNeoplasm Invasiveness
dc.subjectNeovascularization, Pathologic
dc.subjectGadolinium DTPA
dc.subjectDextrans
dc.subjectContrast Media
dc.subjectMagnetic Resonance Imaging
dc.subjectImage Enhancement
dc.subjectSensitivity and Specificity
dc.subjectReproducibility of Results
dc.subjectCell Proliferation
dc.subjectFemale
dc.subjectMagnetite Nanoparticles
dc.subjectMultimodal Imaging
dc.titleInvestigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.
dc.typeJournal Article
dcterms.dateAccepted2016-07-07
rioxxterms.versionofrecord10.1002/nbm.3594
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2016-11
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfNMR in biomedicine
pubs.issue11
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Glioma Team
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Glioma Team
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Pre-Clinical MRI
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Glioma Team
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Glioma Team
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Pre-Clinical MRI
pubs.publication-statusPublished
pubs.volume29
pubs.embargo.termsNo embargo
icr.researchteamGlioma Team
icr.researchteamPre-Clinical MRI
dc.contributor.icrauthorBoult, Jessica
dc.contributor.icrauthorJones, Chris
dc.contributor.icrauthorRobinson, Simon


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0